Enaleni Pharmaceuticals Limited - Dealing In Secur
ENL
ENL
Enaleni Pharmaceuticals Limited - Dealing In Securities By Directors
Enaleni Pharmaceuticals Limited
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
(JSE code: ENL & ISIN: ZAE000067740)
("Enaleni")
DEALING IN SECURITIES BY DIRECTORS
In terms of paragraph 3.63 - 3.65 of the JSE Limited Listings Requirements, the
following information, relating to the sale of ordinary shares on the open
market by Chris Aucamp, an executive director of Cipla Medpro, a major
subsidiary of Enaleni, is disclosed as follows:
Date of transaction: 05 May 2006
Number of shares: 30 000
Price: 430.78 cents per share
Value of transaction: R129 234
Date of transaction: 08 May 2006
Number of shares: 35 500
Price: 436.31 cents per share
Value of transaction: R154 890,05
Extent of interest: Indirect non-beneficial
Written clearance to
deal obtained: Yes
Johannesburg
8 May 2006
Sponsor
Nedbank Capital
Date: 08/05/2006 05:45:08 PM Produced by the JSE SENS Department
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
